Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 503-509

  Salas, Sébastien ^a   Baumstarck Barrau, Karine ^b   Alfonsi, Marc ^c   Digue, Laurence ^a   Bagarry, Danielle ^a   Feham, Nasreddine ^d   Bensadoun, René Jean ^e   Pignon, Thierry ^a   Loundon, Anderson ^b   Deville, Jean Laurent ^a   Zanaret, Michel ^a   Favre, Roger ^a   Duffaud, Florence ^a   Auquier, Pascal ^b  

^a TIMONE HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^c INSTITUT SAINTE CATHERINE   (France)

^d Pasteur Hospital   (France)

^e CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Head and neck carcinoma; Prophylactic gastrostomy; Quality of life; Radio chemotherapy; Randomized trial

Indexed keywords

CARBOPLATIN; FLUOROURACIL;

ADULT; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROSTOMY; HEAD AND NECK CARCINOMA; HUMAN; INTERMETHOD COMPARISON; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

EID: 70449627825     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.05.016     Document Type: Article

References (49)

1. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
2. El-Sayed S., and Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14 (1996) 838-847
3. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
4. Adelstein D.J. Systemic chemotherapy for squamous cell head and neck cancer. Expert Opin Pharmacother 4 (2003) 2151-2163
5. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
6. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
7. Wendt T.G., Grabenbauer G.G., Rodel C.M., et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16 (1998) 1318-1324
8. Bieri S., Bentzen S.M., Huguenin P., et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies. Strahlenther Onkol 179 (2003) 390-395
9. Munshi A., Pandey M.B., Durga T., Pandey K.C., Bahadur S., and Mohanti B.K. Weight loss during radiotherapy for head and neck malignancies: what factors impact it?. Nutr Cancer 47 (2003) 136-140
10. Beaver M.E., Matheny K.E., Roberts D.B., and Myers J.N. Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg 125 (2001) 645-648
11. Newman L.A., Vieira F., Schwiezer V., et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 124 (1998) 589-592
12. Lees J. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Eur J Cancer Care (Engl) 8 (1999) 133-136
13. Duncan W., MacDougall R.H., Kerr G.R., and Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol 41 (1996) 203-207
14. Robertson A.G., Robertson C., Perone C., et al. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis. Radiother Oncol 48 (1998) 165-173
15. Pajak T.F., Laramore G.E., Marcial V.A., et al. Elapsed treatment days - a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 20 (1991) 13-20
16. Wang C.C., and Efird J.T. Does prolonged treatment course adversely affect local control of carcinoma of the larynx?. Int J Radiat Oncol Biol Phys 29 (1994) 657-660
17. Daly J.M., Hearne B., Dunaj J., et al. Nutritional rehabilitation in patients with advanced head and neck cancer receiving radiation therapy. Am J Surg 148 (1984) 514-520
18. Fietkau R., Iro H., Sailer D., and Sauer R. Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Recent Results Cancer Res 121 (1991) 269-282
19. Senft M., Fietkau R., Iro H., Sailer D., and Sauer R. The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients. Support Care Cancer 1 (1993) 272-275
20. Scolapio J.S., Spangler P.R., Romano M.M., McLaughlin M.P., and Salassa J.R. Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile?. J Clin Gastroenterol 33 (2001) 215-217
21. Lee J.H., Machtay M., Unger L.D., et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124 (1998) 871-875
22. Tyldesley S., Sheehan F., Munk P., et al. The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiat Oncol Biol Phys 36 (1996) 1205-1209
23. Nguyen N.P., North D., Smith H.J., et al. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol 15 (2006) 199-203
24. Schag C.C., Heinrich R.L., and Ganz P.A. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2 (1984) 187-193
25. Leplege A., Ecosse E., Verdier A., and Perneger T.V. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 51 (1998) 1013-1023
26. Coste J. Manual and score interpretation. In: Estem, editor. Medical Outcome Study Short Form 36 item health survey. 2001;156 p.
27. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
28. Bjordal K., Ahlner-Elmqvist M., Tollesson E., et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33 (1994) 879-885
29. Salas S., Deville J.L., Giorgi R., et al. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma. Radiother Oncol 87 (2008) 195-200
30. Lopez M.J., Robinson P., Madden T., and Highbarger T. Nutritional support and prognosis in patients with head and neck cancer. J Surg Oncol 55 (1994) 33-36
31. Wiggenraad R.G., Flierman L., Goossens A., et al. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study. Clin Otolaryngol 32 (2007) 384-390
32. Reilly J.J. Does nutrition management benefit the head and neck cancer patient?. Oncology (Williston Park) 4 (1990) 105-115 discussion 115-106
33. Riera L., Sandiumenge A., Calvo C., et al. Percutaneous endoscopic gastrostomy in head and neck cancer patients. ORL J Otorhinolaryngol Relat Spec 64 (2002) 32-34
34. Murphy B.A., Ridner S., Wells N., and Dietrich M. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol 62 (2007) 251-267
35. Gliklich R.E., Goldsmith T.A., and Funk G.F. Are head and neck specific quality of life measures necessary?. Head Neck 19 (1997) 474-480
36. D'Antonio L.L., Zimmerman G.J., Cella D.F., and Long S.A. Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 122 (1996) 482-487
37. Patrick D.L., and Deyo R.A. Generic and disease-specific measures in assessing health status and quality of life. Med Care 27 (1989) S217-232
38. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
39. Leplege A, Ecosse E, Pouchot J, Coste J, Perneger TV. MOS SF36 questionnaire. Manual and guidelines for scores' interpretation. Vernouillet; 2001.
40. Ronis D.L., Duffy S.A., Fowler K.E., Khan M.J., and Terrell J.E. Changes in quality of life over 1 year in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 134 (2008) 241-248
41. van den Berg M.G., Rasmussen-Conrad E.L., van Nispen L., van Binsbergen J.J., and Merkx M.A. A prospective study on malnutrition and quality of life in patients with head and neck cancer. Oral Oncol 44 (2008) 830-837
42. Oates J.E., Clark J.R., Read J., et al. Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 133 (2007) 533-540
43. Ganz P.A., Haskell C.M., Figlin R.A., La Soto N., and Siau J. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer. Cancer 61 (1988) 849-856
44. Siddiqui F., Kohl R., Swann S., Watkins-Bruner D., and Movsas B. Gender differences in pretreatment quality of life in a prospective lung cancer trial. J Support Oncol 6 (2008) 33-39
45. Movsas B., Scott C., and Watkins-Bruner D. Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysis. Int J Radiat Oncol Biol Phys 65 (2006) 830-835
46. Hassan S.J., and Weymuller Jr. E.A. Assessment of quality of life in head and neck cancer patients. Head Neck 15 (1993) 485-496
47. Demiral A.N., Sen M., Demiral Y., and Kinay M. The effect of socioeconomic factors on quality of life after treatment in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 70 (2008) 23-27
48. Weymuller E.A., Yueh B., Deleyiannis F.W., Kuntz A.L., Alsarraf R., and Coltrera M.D. Quality of life in patients with head and neck cancer: lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg 126 (2000) 329-335
49. Hammerlid E., and Taft C. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 84 (2001) 149-156